• 专利附录
  • 专利说明
  • 权利要求
  • 类似技术
  • 同族专利
  • 引用文献
  • 法律状态
  • 优先权
    • 专利摘要:
    The invention relates to topically anti-inflammatory 1-phenylethanolamine derivatives of the general formula I:- or acid-addition salts thereof, to pharmaceutical compositions thereof, and to analogy processes for their manufacture. A representative compound is 1-(4-amino -3,5- dichlorophenyl) -2- [1,1-dimethyl -2- (2-phenylacetamido) ethylamino] ethanol. The derivatives are useful in particular for the treatment of inflammatory diseases or conditions of the akin.
    公开号:SU820658A3
    申请号:SU782650053
    申请日:1978-08-15
    公开日:1981-04-07
    发明作者:Престон Джон；Джон Рив Остин
    申请人:Империал Кемикал Индастризлимитед (Фирма)；
    IPC主号:
    专利说明:

    The invention relates to new derivatives of 1-phenylethanolamine, which have biological activity and can be used in medicine. Phenylethane lamine derivatives of the formula syn-nn- € n-H, JO-one are known (jHj CHj which are obtained when the corresponding imines are reduced by alkali metal hydrofides ll. A method is proposed for the preparation of 1-phenylethanolamine derivatives of the general formula p-5H2ira-JR K -A UHtt where R and R are hydrogen, alkyl C A is alkylene C c - Q is phenylacetyl, phenoxyacety phenylaminocarbonyl or alkanoyl 4 20 salts, which give physiological activity Compounds formudy 1 are prepared according to the invention by reacting an aldehyde of the formula or its hydrite, or hemi-acetal with amine Formulas .A NHQ, where R, R, A and Q are as defined above, in the presence of an alkali metal or cyanoborohydride borohydride in an organic solvent or diluent at a temperature of (-20) (+ 30) C, followed by isolation of the target product as a base or salt The compounds obtained have an anti-inflammatory effect and can be used in the treatment of inflammatory diseases or inflammatory irritations of the skin. In addition, these compounds can also be applied in topical
    treating such diseases or conditions that affect organs, such as the lungs.
    EXAMPLE 1 A mixture of 4-amino-3,5-dichlorophenylglyoxal hydrate (1.18 g and 1,1-dimethyl-2- (2-phenylacetamido) ethyl (1.03 g) in methanol (20 ml by changing QA with the mixture is filtered and the resulting filtrate is thoroughly stirred, a solution of sodium borohydride (5 (P) mg) in water (2 ml) is added dropwise. After stirring for 2 hours, the mixture is acidified, concentrated hydrochloric acid to. pH values are 2-3 and then evaporated. The solid precipitate is suspended in water (50 ml) and the resulting suspension is extracted with ether. (100 ml). The developed aqueous phase is transferred to a base (pH 12-13) by addition of an aqueous solution of ammonia (density, 0. 88) and extracted with ether (2 x 100 ml). The combined extracts are dried (MqS04) and evaporated. The resulting oil is dissolved in propan-2 -ole (5 ml) and the solution prepared with ether is added, bringing the pH to 2-3. With further addition of an excess of dry ether, a precipitate is formed (1.05 g 43%) 1- (4-amine6-3,5-dichlorophenyl) - 2 -f1-dimethyl-2 (2-phenylacetamido) ethylamino-ethanol-dihydrochloride (example 1), mp. 105-8 C.
    Similarly, but using 1,1-dimethyl-2- (2-phenoxyacetamido) -ethylamine and 4-amino-3,5-dichlrphenylglyoxal hydrate as starting materials, 1- (4-amino-3,5dichlorophenyl) -2 - Tl, 1-dimethyl-2 {2phenoxyacetalsdo) - ethylaminoethanol with a yield of 35%, so pl. UT-SW C (hydrochloride, monohydrate).
    PRI mme R 2. A mixture of 4-akouno-3,5-dichlorophenylglyoxal hydrate (1.16 and 1,1-dimethyl-2- (stearoylamino) ethylemine (1.77 g) in methanol (25 g) is stirred in for 16 hours and during this time a white solid precipitate gradually precipitates. Then, to the mixed suspension, drop a solution of sodium borohydrate (500 g) in water (5 g) to the mixed suspension. At the same time, the white solid dissolves to obtain a clear solution. After stirring for 2 hours the mixture is acylated with acetic acid to pH 5 and then evaporated.
    The resulting solid residue is suspended in water (50 ml) and formed: the suspension is extracted with ether (2 X 50 ml). The extracts are stirred, dried (Atg50 and evaporated to give an oil, which is dissolved in ether (25 ml). The resulting solution is cooled and separated 1-H-amino-3,5-dichlorophenyl) 2-Cll dimethyl-2- (aroylamino ) - ethylamino - ethanol 10.9 g 40%), so pl. 74 - 76 ° C
    Example 3. A mixture of 4-amino-3,5-dichlorophenylglyoxalhydrate (1.77 g) and 1,1-dimethyl-2J - (phenylureido) - ethylamine (1.55 g) in methanol (30 ml) is stirred for 30 minutes . The mixture is then treated dropwise with a solution of 4-bO1 sodium hydride (750 mg) in water (5 mp). After mixing
    the mixture is oxidized for more than 2 hours
    acetic acid to pH 5 and then evaporated. The resulting solid os / tat is suspended in water (50 ml). The resulting cus-pency is extracted with ether (2x100 ml)
     / Purified extracts dried
    (MqS04) and evaporated to give a mixture, which was dissolved in propan-2-ol (5 ml). Hydrogen chloride ester is added to the resulting solution to adjust the pH to 2-3. 1 (4-amino-3,5-dichlorophenyl) -2- 1,1-dimethyl-2- (phenylureido) -ethylamino) :: ethanol-hydrochloride is obtained in the form of a solid, which is recrystallized from methanol and ether, to give the desired product (1.2 g} 36%), so pl. 197-1980C.
    PRI me R 4. A mixture of 4-amino-3,5 dichlorophenylglyoxal hydrate (2.35 g)
    n and 1,1-dimethyl-2- (2-phenylacetamido) ethylamine (2.06 g) in acetonitrile (50 ml) and bite acid (3 ml) peremanyvat for 30 minutes Sodium cyanoborohydride (1.26 ml) was added to the reaction mixture in portions
    within 5 minutes After stirring for 16 hours, the mixture is evaporated and the residue is partitioned (10% by volume) in a mixture of aqueous acetic acid (100 ml) and ethyl acetate.
    0 {100 ml). The organic phase is separated, dried (MqS) H and evaporated. The semi-solid K is dissolved. The residue is dissolved in propan-2-ol (10 ml), and the solution is added with ether chloride,
    5 pH argument to 2-3. After adding dry ether, a precipitate is obtained (2.8 g; 63%) with 1- (4-amino-3,5-dichlorophenyl) -2-1,1-dimethyl-2- (2-phenylacetamido) ethylamino-ethanol-dihydQ Rochloride, so pl. 105-108 S.
    The free base (mp. 9698c) is obtained by adding a 10% excess of dihydrochloride to a mixture of sodium hydrogen carbonate — ether (1: 1 by volume), separating and evaporating the dried (MqSO) extracts.
    PRI me R 5. Applying the procedure described in Example 1, from 4-amino-3, 5-dichlorophenylglyoxal-g1 dretha and H (-2-phenylacetyl) ethylenediamine C, one can GET 1- (4-amino-3 , 5-dichlorophenyl) (2-phenylacetamido) - ethylamino-ethanol-hydrochloride, so pl. 118-120 ° C, yield 30-40%.
    The compounds of formula T, obtained 65 according to the proposed method, possess
    anti-inflammatory activity when applied topically to the area of inflammation and can be used to treat inflammatory diseases or inflammatory skin irritations.
    The anti-inflammatory properties of the compounds of the formula T are proved by conducting standard tests using croton oil, which induces inflammation in the ear of the mouse. The activity of an individual compound in this test depends on its specific chemical structure, however, significant inhibition of growth is observed at a topically applied dose of 10.20 mg per ear or less.
    In carrying out the above tests, no clear toxic effects have been established at. active dosing.
    For topical treatment of the inflamed area, damaging the skin of a mammal, such as a human, the compounds of formula T can be administered as an average daily dose of 20 to 15 mg, or as an equivalent dose of their pharmaceutically acceptable acid addition salt. The amount of compound given during the day for treatment depends on the degree of severity and the focus of inflammation to be treated.
    权利要求:
    Claims (1)
    [1]
    1. Patent IT 3437.731.1. cl. 424-330, published. 1969.
    类似技术:
    公开号 | 公开日 | 专利标题
    SU820659A3|1981-04-07|Method of preparing 4-amino-5-alkylsulfonyl-o-anisamide derivatives,their salts,oxides,left-and right-rotational isomers |
    EP0005848B1|1981-12-30|N-alkylated aminoalcohols and their salts, process for their preparation and pharmaceutical compositions containing them
    SU1729291A3|1992-04-23|Method of catching derivatives synthesis
    FR2540495A1|1984-08-10|NOVEL DERIVATIVES OF O-MERCAPTOPROPANAMIDE AND ITS HOMOLOGISTS, PROCESS FOR PREPARING THEM, THEIR APPLICATION AS MEDICAMENTS, THE COMPOSITIONS CONTAINING SAME, AND THE NEW INTERMEDIATES OBTAINED
    FR2515039A1|1983-04-29|SULFODEHYDROABIETIC ACID SALTS AND THEIR USE FOR THE TREATMENT OF GASTROINTESTINAL DISEASES
    JPH08269006A|1996-10-15|Aniline derivative having inhibiting activity against nitrogen monoxide synthetase
    SU1706388A3|1992-01-15|Method for synthesis of thiazolylcarbamoyl-substituted ether derivatives of nitric acid or theirs additive salts with haloid acids
    SU1241986A3|1986-06-30|Method of producing benzamide derivatives,hydrochlorides thereof or optical isomers
    RU2417217C2|2011-04-27|Salt clusters of ammonium salt and mineral salt with dibasic acid anions which are resistant and stable during storage and synthesis method thereof
    CA2101058A1|1993-05-23|Novel compounds having a guanidine structure and pharmaceutical composition containing same
    SU820658A3|1981-04-07|Method of preparing 1-phenylethanolamine derivatives or their salts
    EP0001193A1|1979-03-21|Carbocylic amino acids, methods for their preparation and pharmaceutical compositions containing them
    RU2036929C1|1995-06-09|Estramastin esters or their pharmaceutically acceptable salts and a method of their synthesis
    HU195486B|1988-05-30|Process for preparing new pyridine derivatives
    EP0117196B1|1986-07-30|Derivatives of n-iminopyridinium betaines, their preparation and their use as medicaments
    SU867303A3|1981-09-23|Method of preparing tetrahydro-1,3,5-triazn-2,6-dione derivatives or their basic salts
    CA1171421A|1984-07-24|Lysine salts having analgesic activity
    FR2476071A1|1981-08-21|NOVEL 2-AMINO-3- | -PHENYLACETIC ACIDS AND THEIR ESTERS AND AMIDES, PARTICULARLY USEFUL AS ANTI-INFLAMMATORY AGENTS, AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
    KR840000763B1|1984-06-08|Process for the preparation of 2-amino-3-benzoyl-phenylacetamides
    EP0000452B1|1981-05-06|1,2,4-oxadiazol derivatives, their preparation and application in pharmaceutical compositions
    CA1091249A|1980-12-09|Process for the preparation of novel n-acyl- glutamines and compositions produced therefrom
    EP0280603A1|1988-08-31|Absolute S confirmation enantiomers of amide derivatives of 3-aminoquinuclidine, process for their preparation and their therapeutical use
    EP0119107A1|1984-09-19|Derivatives of bicyclo|octatriene-1,3,5, their preparation and their therapeutical application
    EP0138714A2|1985-04-24|1-|-2-amino-propanone derivatives, their therapeutical use and process for their preparation
    US4446151A|1984-05-01|Decarboxylase-inhibiting fluorinated pentane diamine derivatives
    同族专利:
    公开号 | 公开日
    IL55284D0|1978-10-31|
    US4355045A|1982-10-19|
    ATA595378A|1980-04-15|
    AR221704A1|1981-03-13|
    NL7808440A|1979-02-20|
    PL113842B1|1981-01-31|
    FI782498A|1979-02-17|
    EP0000809B1|1982-04-14|
    PL215005A1|1979-12-17|
    ES472591A1|1979-10-16|
    NO782767L|1979-02-19|
    IT1098051B|1985-08-31|
    NO145656B|1982-01-25|
    AT359481B|1980-11-10|
    HU177107B|1981-07-28|
    CS207661B2|1981-08-31|
    IL55284A|1981-10-30|
    DE2835537A1|1979-03-01|
    PT68422A|1978-09-01|
    JPS5448727A|1979-04-17|
    CA1108183A|1981-09-01|
    IT7826671D0|1978-08-10|
    FR2400505B1|1981-01-30|
    AU3850578A|1980-02-07|
    AU521456B2|1982-04-01|
    EP0000809A1|1979-02-21|
    BE869639A|1979-02-09|
    PL114031B1|1981-01-31|
    GR66025B|1981-01-13|
    ZA784335B|1979-07-25|
    PL209049A1|1979-08-27|
    NO145656C|1982-05-05|
    FI70008C|1986-09-12|
    IE781519L|1979-02-16|
    NZ188040A|1981-07-13|
    IE47283B1|1984-02-08|
    FR2400505A1|1979-03-16|
    FI70008B|1986-01-31|
    DK362178A|1979-02-17|
    DE2861733D1|1982-05-27|
    引用文献:
    公开号 | 申请日 | 公开日 | 申请人 | 专利标题
    DE1618005A1|1966-09-22|1971-09-09|Thomae Gmbh Dr K|Process for the preparation of new amino-dihalogen-phenyl-ethylamines|
    US3975443A|1972-06-06|1976-08-17|Allen & Hanburys Limited|1--cyclohexyldimethylamine|
    GB1460593A|1973-06-22|1977-01-06|Ici Ltd|Ethanolamine derivatives|
    GB1468156A|1973-07-19|1977-03-23|Ici Ltd|Phenylethylamine derivatives|IE54220B1|1981-12-23|1989-07-19|Ici Plc|Phenol esters|
    US5541188A|1987-09-15|1996-07-30|The Rowett Research Institute|Therapeutic applications of beta-adrenergic agonists|
    US5530029A|1987-09-15|1996-06-25|The Rowett Research Institute|Therapeutic applications of clenbuterol|
    FR2626878B1|1988-02-10|1990-06-08|Lafon Labor|1--2-DIMETHYLAMINOPROPANONE DERIVATIVES, PREPARATION METHOD AND THERAPEUTIC USE|
    US6421336B1|1999-02-23|2002-07-16|Tantivy Communications, Inc.|Variable rate orthogonally coded reverse link structure|
    法律状态:
    优先权:
    申请号 | 申请日 | 专利标题
    GB3434677|1977-08-16|
    [返回顶部]